Last updated on August 2019

A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Brief description of study

The reason for this study is to see if the study drug baricitinib given orally is safe and effective in participants with JIA from 2 years to less than 18 years old.

Clinical Study Identifier: NCT03773978

Find a site near you

Start Over

HELIOS Klinikum Berlin-Buch

Berlin, Germany
  Connect »